COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1154
https://www.valueinhealthjournal.com/article/S1098-3015(16)01222-5/fulltext
Section Title : Muscular-Skeletal Disorders - Cost Studies
Section Order : 828
First Page : A234
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01222-5&doi=10.1016/j.jval.2016.03.1154
HEOR Topics :
Tags :
Regions :